BioClinica, Inc. plans continued investments in its European workforce in the areas of operations and sales, potentially doubling its European eClinical presence in 2014. According to the company, Europe was the fastest growing geographic region in 2013 for its eClinical technology products. The company’s European operations support its suite of eClinical offerings, including CTMS, EDC, IRT, and clinical supplies planning. Currently, the company has offices in Lyon, France; Leiden, The Netherlands; and Munich, Germany, with additional personnel in Switzerland, Belgium and the UK.
 
According to Martijn Princen, BioClinica’s head of European eClinical Sales, “One of the pillars for success in this or any geographic market essentially is the eClinical technology itself. With a web-based, easy-to-use platform, supported by experienced people on the ground here in Europe, more and more companies are selecting BioClinica for both European and global studies.”
        
BioClinica will host its first European User Conference in Cologne, Germany on February 26, which will feature presentations from Johnson & Johnson, Nestle, Grunenthal, Sanofi, Biosense Webster, TauRx, and Cerbomed. BioClinica Technology Partner NNIT will lead a session on SharePoint implementation, systems integration, and validation.
 
“In terms of innovation, OnPoint CTMS and Trident IRT have been the big attention-getters, driven by the need for better speed and flexibility that is central to clinical research. For example, a CTMS needs to grow with an organization and have capacity to manage complex clinical trials long-term,” Mr. Princen added. “Now the trend is for large and mid-size sponsors and CROs to replace their existing CTMS with a more sophisticated end-to-end clinical trial management solution.”